Inflammatory responses and osteoclast differentiation play pivotal roles in the pathogenesis of osteolytic bone diseases such as periodontitis. Although overexpression or inhibition of peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 (PIN1) offers a possible therapeutic strategy for chronic inflammatory diseases, the role of PIN1 in periodontal disease is unclear. The aim of the present study was to evaluate PIN1 expression in periodontitis patients as well as the effects of PIN1 inhibition by juglone or PIN1 small-interfering RNA (siRNA) and of PIN1 overexpression using a recombinant adenovirus encoding PIN1 (Ad-PIN1) on the inflammatory response and osteoclastic differentiation in lipopolysaccharide (LPS)-and nicotine-stimulated human periodontal ligament cells (PDLCs). PIN1 was up-regulated in chronically inflamed PDLCs from periodontitis patients and in LPS-and nicotine-exposed PDLCs. Inhibition of PIN1 by juglone or knockdown of PIN1 gene expression by siRNA markedly attenuated LPS-and nicotine-stimulated prostaglandin E 2 (PGE 2 ) and nitric oxide (NO) production, as well as cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression, whereas PIN1 overexpression by Ad-PIN1 increased it. LPS-and nicotine-induced nuclear factor (NF)-κB activation was blocked by juglone and PIN1 siRNA but increased by Ad-PIN1. Conditioned medium prepared from LPS-and nicotinetreated PDLCs increased the number of tartrate-resistant acid phosphatase-stained osteoclasts and osteoclast-specific gene expression. These responses were blocked by PIN1 inhibition and silencing but stimulated by Ad-PIN1. Furthermore, juglone and PIN1 siRNA inhibited LPS-and nicotine-induced osteoclastogenic cytokine expression in PDLCs. This study is the first to demonstrate that PIN1 inhibition exhibits anti-inflammatory effects and blocks osteoclastic differentiation in LPS-and nicotine-treated PDLCs. PIN1 inhibition may be a therapeutic strategy for inflammatory osteolysis in periodontal disease.
Introduction
Both the periodontal microflora and the host response play critical roles in the initiation and progression of periodontal diseases (Albandar 2002) . Lipopolysaccharide (LPS) from gram-negative bacteria is thought to be an important pathogenic factor and to contribute to alveolar bone resorption by inducing inflammatory cytokines, such as interleukin (IL)-1β, tumor necrosis factor (TNF)-α, and prostaglandin E 2 (PGE 2 ), in macrophages and neutrophilic leukocytes (Guiglia et al. 2013) . Moreover, inducible nitric oxide synthase (iNOS)derived nitric oxide (NO) and cyclooxygenase-2 (COX-2)derived PGE 2 levels play an important role in periodontitis by mediating inflammatory reactions in periodontal tissues (Leitão et al. 2005; Kurtis et al. 2007 ). LPS reportedly increases osteoclast formation by stimulating the receptor activator of nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB)/receptor activator of NF-κB ligand (RANK/RANKL) signaling system (Sato et al. 2004 ). Thus, potential therapeutic strategies for the treatment of chronic inflammatory diseases (e.g., periodontitis) have been proposed; these include suppressing inflammatory responses and blocking osteoclast differentiation (Jimi et al. 2004) .
Tobacco smoking may be an important risk factor for the development and severity of periodontitis (Johnson and Guthmiller 2007) . Nicotine, one of the most abundant components of tobacco smoke, has been detected in the saliva and gingival crevicular fluid of smokers (McGuire et al. 1989 ). Thus, periodontal ligament cells (PDLCs) treated with nicotine plus LPS might be an in vitro model relevant to periodontitis in smokers with poor oral hygiene (Jeong GS et al. 2009; Pi et al. 2010; Jeong et al. 2011; Kim et al. 2012; Lee et al. 2013) . The combination of nicotine and LPS exerts a synergistic effect on the expression and production of inflammatory mediators, including NO and PGE 2 , and on the expression of iNOS and COX-2 in PDLCs (Jeong GS et al. 2009; Pi et al. 2010; Kim et al. 2012) . Conditioned medium (CM) from nicotine and LPS-treated Saos-2 osteoblasts stimulates the formation of osteoclastlike cells by increasing macrophage colony-stimulating factor (M-CSF) and PGE 2 , compared with that produced by nicotine treatment alone (Tanaka et al. 2006) . Our recent study demonstrated that nicotine and LPS treatment upregulate the mRNA expression of osteoclast markers, including RANKL and M-CSF in PDLCs ). These results suggest that alveolar bone resorption in smokers is increased further by insufficient mouth cleaning.
Protein phosphorylation is a key cellular signaling mechanism that induces changes in protein conformation (Lu and Zhou 2007) . Peptidyl-prolyl cis/trans isomerase NIMAinteracting 1 (PIN1) has been identified as a regulator of phosphorylation signaling that plays a part in the regulation of cell growth, genotoxic and other stress responses, and differentiation (Lu and Zhou 2007; Lee YM et al. 2014) . It was recently demonstrated that PIN1 may be a therapeutic target in the treatment or prevention of inflammatory disease. In vivo inhibition of PIN1 by juglone reduced eosinophilic pulmonary inflammation in rat asthma (Esnault et al. 2007 ), rat allergic lung fibrosis (Shen et al. 2008) , kidney fibrosis in rat ureteral occlusion (Reese et al. 2010) , and inflammation in mice with type II collagen-induced rheumatoid arthritis (RA; Jeong HG et al. 2009 ). In vitro inhibition of PIN1 by juglone and PIN1 small-interfering RNA (siRNA) blocked ultraviolet A radiation-stimulated COX-2 expression and PGE 2 production in mouse epidermal cells (Quyen et al. 2013 ) and decreased COX-2 expression in primary cultured chondrocytes from RA patients (Jeong HG et al. 2009 ). However, PIN1 knockdown in endothelial cells increased COX-2 induction and PGE 2 production by LPS/interferon (Liu et al. 2009 ). In contrast, PIN1 overexpression by a PIN1 adenovirus (Ad-PIN1) attenuated carbon tetrachloride-induced acute liver injury in mice by modulating apoptotic signals and increasing NF-κB activity (Risal et al. 2012 ). Furthermore, PIN1 -/mice showed markedly worse liver injury after ischemia/reperfusion (Kuboki et al. 2009 ), significant bone loss with aging ), reduced bone mineral density and trabecular bone volume (Shen et al. 2013) , and larger osteoclasts without changes in the osteoclast number (Islam et al. 2014) .
The transcription factor NF-κB regulates the expression of inflammatory genes, such as COX-2 and iNOS (Pi et al. 2010) . PIN1 binds to the phosphorylated Thr 254 -Pro motif of p65 and subsequently inhibits IκBα binding, which increases the nuclear localization and activity of NF-κB (Ryo et al. 2003) . Moreover, PIN1-knockout mice had reduced hepatic NF-κB activation and more liver injury after ischemia/reperfusion injury than did wild-type mice (Kuboki et al. 2009 ). We hypothesized that PIN1 may play a role in osteoclastogenesis and inflammatory response, as PIN1 is expressed in bone tissue, and primary cultured osteoblasts and osteoclasts (Shen et al. 2013) , and PIN1 inhibition or overexpression exerts anti-inflammatory effects in various disease models.
The aim of the present study was to (1) investigate whether PIN1 is up-regulated in patients with periodontitis and in nicotine-and LPS-stimulated human PDLCs, (2) assess whether PIN1 inhibition or overexpression suppresses the nicotine-and LPS-induced inflammatory response in PDLCs and osteoclastic differentiation in mouse bone marrow-derived macrophages (BMMs), and (3) identify the underlying mechanisms in human PDLCs.
Materials and Methods

Gene Expression Profiling
To compare PIN1 mRNA expression between normal and diseased periodontal tissues, publicly available gene expression data sets for human samples were retrieved from the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) database (accession No. GSE7321, http:// www.ncbi.nlm.nih.gov/geo/). GSE7321 is a microarray data set obtained from 32 patients at the Dental Medical School of the University of Göttingen (12 men, 20 women, aged 18-72 y) from March 2005 to December 2005 (Gersdorff et al. 2008 ). Determination of healthy and chronically inflamed PDLC groups was performed using clinical and radiological parameters (i.e., clinical attachment loss, increase in probing depth, and radiographic bone loss). Teeth with healthy PDL had no clinical signs of inflammation (no bleeding on probing), exhibited a probing depth of 3.5 mm, and had no detectable radiographic bone loss. In contrast, teeth with generalized chronic inflammation exhibited obvious clinical signals of inflammation, including a probing depth of >4 mm and radiographic evidence of bone loss (1-5 mm).
Patients and Biopsies
Gingival biopsies were obtained from 15 subjects undergoing periodontal surgery for disease-related or non-diseaserelated (e.g., esthetic) reasons at the Department of Periodontology, Kyung Hee University Dental Hospital (Seoul, Korea). Biopsies were harvested from single teeth and divided into 3 groups as follows: (1) healthy group (systemically and periodontally healthy subjects, with a high standard of oral hygiene, no bleeding on probing, and probing depth ≤ 3 mm in the selected sites; n = 5), (2) periodontitis group (subjects who had never smoked, were systemically healthy, and were clinically diagnosed with severe chronic periodontitis [e.g., probing depth ≥ 7 mm and bleeding on probing]; n = 5), and (3) smoking group (systemically healthy subjects clinically diagnosed with severe chronic periodontitis [e.g., probing depth ≥7 mm and bleeding on probing] who had smoked ≥1 pack per day for at least 10 y; n = 5). Informed consent to use the tissues was obtained at the time of surgery.
Cell Culture
Immortalized human dental periodontal ligament cells transfected with the human telomerase catalytic component (hTERT) were kindly provided by Professor Takashi Takata (Hiroshima University, Japan; Kitagawa et al. 2006 ). Cells were cultured at 37 °C in Minimal Essential Medium α (α-MEM) supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 µg/mL streptomycin in a humidified atmosphere of 5% CO 2 .
Preparation of Recombinant PIN1 Adenovirus
An adenovirus encoding PIN1 (kindly provided by Professor Byung-Hyun Park, Jeonbuk National University and Republic of Korea) was created using the ViraPower Adenovirus Expression System according to the manufacturer's instructions (Invitrogen, Carlsbad, CA, USA). The adenovirus was prepared and amplified as described previously (Zhou et al. 2013) . The virus (MOI 100) was added to cells.
PIN1 siRNA Transfection
Cells were incubated in 6-well plates for 24 h and then transfected with control siRNA, PIN1 siRNA, or NF-κB siRNA (Bioneer Corporation, Daejeon, South Korea) using Lipofectamine 2000 (Gibco; Invitrogen Ltd., Paisley, UK) according to the manufacturer's instructions.
Isolation of RNA and Reverse Transcription-Polymerase Chain Reaction
Total RNA was extracted from cells and tissues using TRIzol reagent (Life Technologies, Gaithersburg, MD, USA) according to the manufacturer's instructions. cDNA synthesis was performed using an AccuPower RT PreMix kit (Bioneer Corporation) and oligo-dT primers. Primer sequences used for reverse transcription-polymerase chain reaction (RT-PCR) analysis were listed in our previous studies Lee YM et al. 2014 ). The PCR products were resolved on a 1.2% agarose gel and stained with ethidium bromide.
Western Blot Analysis
Cells were solubilized in ice-cold 1% Triton X-100 lysis buffer. Proteins (20 µg) were mixed with an equal volume of 2× sodium dodecyl sulfate (SDS) sample buffer, boiled for 5 min, resolved by SDS-polyacrylamide gel electrophoresis (PAGE; 12% acrylamide), and transferred to nitrocellulose membranes. Protein bands were visualized by enhanced chemiluminescence (ECL) according to the manufacturer's instructions and exposed to X-ray film.
Immunofluorescence Confocal Microscopy
Treated cells were fixed with cold 4% paraformaldehyde and blocked by treatment with 2% bovine serum albumin in Tris-buffered saline for 1 h, then incubated with rabbit anti-NF-κB p65 antibody (1:200; Santa Cruz Biotechnology, Santa Cruz, CA, USA). Cells were further incubated with a 1:1,000 dilution of DyLight 488 goat anti-rabbit immunoglobulin (Ig)G (Abcam, Cambridge, MA, USA) for 1 h. The samples were counterstained with 5 µg/mL propidium iodide for 15 min to identify the nuclei and analyzed by confocal microscopy (Carl Zeiss, Jena, Germany).
Quantification of NO and PGE 2 Levels
Total NO production was determined as the nitrite concentration in the culture medium using a spectrophotometric assay based on the Griess reaction. The concentrations of PGE 2 in culture supernatants were determined using an enzyme-linked immunosorbent assay kit (R&D Systems, Minneapolis, MN, USA), according to the manufacturer's recommendations.
Osteoclast Differentiation Assays
Mouse BMMs obtained from 5-wk-old female ICR mice (Charles River Laboratories, Seoul, Korea) were used as osteoclast precursor cells for in vitro osteoclastogenesis experiments. CM was prepared from PDLCs treated with nicotine plus LPS, juglone, PIN1 siRNA, and Ad-PIN1 for 24 h. Mouse BMMs were incubated overnight in culture dishes with α-MEM supplemented with 10% FBS. After attached cells were discarded, floating cells were further cultured for 3 d in the presence of M-CSF (30 ng/mL). Upon 2-d treatment of BMMs with 30 ng/mL M-CSF and 100 ng/mL RANKL, >80% of the cells became mononuclear tartrate-resistant acid phosphatase (TRAP)-positive cells (preosteoclasts). To evaluate the osteoclastogenic activity of CM from PDLCs, we treated preosteoclasts with the CM mixture (60% CM plus 40% fresh α-MEM without M-CSF and RANKL) and further cultured the cells for up to 4 d to achieve mature osteoclast differentiation, as described previously Lee SI et al. 2014) . After 4 d of culture, cells were stained for TRAP activity with a leukocyte acid phosphatase kit (Sigma, St. Louis, MO, USA).
Co-immunoprecipitation
Stimulated cells were lysed in protein extraction solution (cat. No. 17081; iNtRON Biotechnology, Korea) containing protease and phosphatase inhibitor cocktail (Pierce Biotechnology, Rockford, IL, USA) and then centrifuged at 12,000 g for 15 min at 4 °C. Following protein isolation, 500 µg of total protein per sample was diluted with coimmunoprecipitation buffer and precleaned with normal mouse IgG and proteinA/G-plus beads (Santa Cruz Biotechnology) and then immunoprecipitated with an anti-PIN1 (Santa Cruz Biotechnology) antibody, respectively, overnight at 4 °C. After washing, the beads were boiled in 20 µL of SDS sample buffer, and 10 µL of the eluate was fractionated by 12% SDS-PAGE followed by Western blotting with anti-PIN1 or anti-p65 antibody. The reactive bands were detected with an ECL system (Amersham, Amersham, UK), used according to the manufacturer's instructions.
RNA Extraction and RT-PCR
Total RNA was isolated using Trizol (Invitrogen) and reversetranscribed to cDNA with RT Master Mix (Bioneer Corporation). The primers used to amplify PIN1 were 5′-AGG ACT TTG AGT CTC TGG CCT CAC-3′ (forward; F) and 5′-AGG CGT CTT CAA ATG GCT TCT G-3′ (reverse; R). The primers used to amplify β-actin cDNA were 5′-CAT GGA TGA TGA TAT CGC CGC G-3′ (F) and 5′ACA TGA TCT GGG TCA TCT TCT CG-3′ (R). Quantitative real-time PCR (qRT-PCR) was performed using SYBR Green PCR Master Mix (Roche Diagnostics, Basel, Switzerland) using the LightCycler (Roche Molecular Biochemicals, Indianapolis, IN, USA). Samples were run in triplicate, and the efficiency of each primer was calculated using an internal standard control. All values were normalized to that of β-actin.
Statistical Analysis
Data are expressed as the means ± standard deviation. Comparisons were performed using a 1-way analysis of variance (SPSS version 22.0, Chicago, IL, USA). All experiments were repeated at least 3 times, and results from representative experiments are shown.
Results
mRNA Expression of PIN1 in Healthy Controls and Periodontitis Patients
To determine the role of PIN1 in periodontal disease, we searched expression data for PIN1 in public expression databases and for probe set 200879_s_at on the Affymetrix U133 2.0+ platform in GEO (NCBI) for normal and diseased periodontal tissues. According to the expression data sets, mRNA expression of PIN1 was 39.97% higher in chronically inflamed PDLCs from patients with periodontitis compared with healthy PDLCs (Fig. 1A) .
To verify the mRNA expression of PIN1 in periodontal tissue harvested from periodontal patients, gingival biopsies were taken from healthy and periodontally diseased individuals ( Fig. 1B) . PIN1 mRNA expression was significantly higher in patients with periodontitis than in periodontally healthy subjects. Furthermore, smoker subjects with periodontitis had a statistically significantly higher PIN1 expression than did nonsmoker periodontitis patients (P < 0.05).
Effects of Nicotine and LPS on PIN1 Protein Expression in Human PDLCs
To evaluate the effects of nicotine and LPS on PIN1 expression, human PDLCs were treated with various concentrations of nicotine and LPS for 24 h (Fig. 1C) , which resulted in a concentration-dependent up-regulation of PIN1 protein compared with treatment of LPS or nicotine alone. Maximal induction of PIN1 was observed when the cells were treated with 1 µg/mL LPS plus 5 mM nicotine for 24 h.
Effects of PIN1 Inhibition and Overexpression on the Nicotine-and LPS-Induced Inflammatory Response in PDLCs
To understand the role of PIN1 in an in vitro model of periodontal disease, a series of functional studies was performed by inhibiting PIN1 with juglone, knocking down PIN1 expression with PIN1 siRNA, and overexpressing PIN1 with a PIN1-expressing adenovirus (Ad-PIN1) in nicotine-and LPS-stimulated PDLCs. Pretreatment with juglone concentration-dependently inhibited nicotine-and LPS-induced PIN1 expression, protein expression of inflammatory mediators such as COX-2 and iNOS, and production of NO and PGE 2 (Fig. 1D-F) . As shown in Figure  2 , PIN1 siRNA knockdown significantly attenuated the effects of nicotine and LPS on COX-2 and iNOS protein expression, as well as NO and PGE 2 production, whereas a control siRNA showed no effect in PDLCs. Moreover, adenovirus-mediated PIN1 overexpression accentuated nicotine-and LPS-induced COX-2 and iNOS up-regulation as well as production of NO and PGE 2 ( Fig. 2A-C) .
Effects of PIN1 Inhibition and Overexpression on Nicotine-and LPS-Induced NF-κB Activation
The effects of PIN1 inhibition and activation on NF-κB signaling were assessed by Western blotting and confocal microscopy (Fig. 3A, B) . Treatment with a PIN1 inhibitor and PIN1 siRNA blocked LPS-and nicotine-induced degradation of IκBα, phosphorylation of IκBα, and nuclear translocation of p65. By contrast, pretreatment with Ad-PIN1 increased NF-κB activation. In an immunofluorescence assay, NF-κB/p65 nuclear translocation in LPS-and nicotine-stimulated PDLCs was decreased by PIN1 inhibition but increased by Ad-PIN1 (Fig. 3B) .
To determine whether a p65-PIN1 interaction occurs in PDLCs, co-immunoprecipitation experiments were performed. Immunoprecipitation was then carried out using an anti-PIN1 antibody, followed by immunoblotting for p65 and PIN1 (Fig.  3C) . Endogenous PIN1 and p65 interacted in the unstimulated state, which was enhanced upon nicotine and LPS stimulation. This suggests that physical interaction between PIN1 and p65 could increase the stability and nuclear translocation of p65 through inhibition of IκBα binding to p65.
Effects of PIN1 Inhibition and Overexpression on Osteoclastogenesis
To examine whether PIN1 inhibition and overexpression affected nicotine and LPS-mediated osteoclastogenic molecules, PDLCs were either transfected with PIN1 siRNA or Ad-PIN1 and pretreated with juglone, following 24-h exposure to nicotine and LPS. Juglone and PIN1 siRNA blocked nicotine-and LPS-induced up-regulation of RANKL. However, Ad-PIN1 enhanced nicotine-and LPS-stimulated RANKL expression ( Fig. 4A) .
To elucidate the effects of PIN1 inhibition and activation on osteoclastogenesis in vitro, preosteoclasts were allowed to differentiate into mature osteoclasts in CM prepared from PDLCs treated with nicotine plus LPS, juglone, PIN1 siRNA, or Ad-PIN. TRAP staining revealed that osteoclast formation was increased in PIN1-overexpressing cells but decreased by juglone and PIN1 siRNA (Fig. 4B, C) . RANKL-induced expression of osteoclastogenesis marker genes, such as cathepsin K, c-fos, and NFATc1, were upregulated by PIN1 overexpression but down-regulated by PIN1 inhibition (Fig. 4D) .
To identify possible destructive mediators of LPS-and nicotine-stimulated PIN1 expression, a broad range of proinflammatory cytokines implicated in osteoclast differentiation was examined. PIN1 inhibition attenuated LPS-and ) secretion (D, E). Cells were incubated for 24 h with the indicated concentrations of nicotine and LPS (B). Cells were pretreated with juglone for 1 h and then stimulated with LPS (1 µg/mL) plus nicotine (5 mM) for an additional 24 h (C, D, E). Production of NO and PGE 2 was measured using the Griess assay and enzyme-linked immunosorbent assay (ELISA), respectively. Protein expression was determined by Western blot analysis. Western blot data representative of 3 independent experiments with similar results are shown. *P < 0.05 versus control; #P < 0.05 versus nonsmoker periodontitis or versus LPS plus nicotine (n = 4).
nicotine-induced TNF-α, IL-1β, IL-6, IL-11, IL-17, and IL-23 mRNA expression, whereas PIN1 activation had the opposite effect. IL-15 was not affected by PIN1 inhibition or overexpression (Fig. 5A) .
To confirm that the NF-κB pathway was involved in the LPS-and nicotine-induced production of inflammatory mediators in PDLCs, we used an NF-κB inhibitor, pyrrolidine dithiocarbamate (PDTC), or NF-κB gene silencing. PDTC and NF-κB siRNA decreased the nicotine-and LPSinduced expression of iNOS and COX-2 proteins as well as NO and PGE 2 production ( Fig. 5B-D) . In addition, LPSand nicotine-mediated TNF-α, IL-1β, IL-6, IL-11, IL-17, and IL-23 mRNA induction were inhibited by PDTC and NF-κB siRNA (Fig. 5E ).
Discussion
In the present study, we used a PDLC line immortalized by hTERT transfection (Kitagawa et al. 2006 ), which retains the features of their original primary cells (i.e., PDLCs). Thus, this immortalized cell line is a helpful tool for studying the biology and mechanisms of PDLCs.
PIN1 mRNA or protein up-regulation was detected in vivo in periodontitis patients based on publicly available microarray data (Gersdorff et al. 2008) and our real-time PCR data, as well as in vitro in PDLCs stimulated with the major periodontopathogens, nicotine, and LPS. Up-regulation of PIN1 was also observed in radiation-exposed mouse skin tissues and JB6 Cl41 epidermal cells (Han et al. 2011 ) and in chondrocytes, lymphocytes, and fibroblasts from RA lesions in mice with type II collagen-induced RA (Jeong HG et al. 2009 ). Since PIN1 is up-regulated in periodontitis patients and nicotine-and LPS-stimulated PDLCs, we evaluated PIN1 as a potential target for periodontitis.
Juglone, 5-hydroxy-1,4-naphthoquinone, inhibits members of the parvulin peptidyl-prolyl isomerase (PPIase) family and functions by modifying sulfhydryl groups (Hennig et al. 1998 ). The compound irreversibly inhibits the enzymatic activity of PIN1 by inactivating a unique cysteine residue in the PIN1 active site (Hennig et al. 1998 ). It has been suggested that juglone inhibits transcription in vitro by inhibiting preinitiation complex formation by modifying sulfhydryl groups of RNA polymerase II (Chao et al. 2001) . Juglone is frequently used to explore the relevance of PIN1 function in in vivo and in vitro, particularly since it often phenocopies the effects of PIN1 dominant-negative mutants or PIN1 knockdown (Esnault et al. 2007; Reese et al. 2010) . PIN1 transcription and its protein levels fluctuate during cell cycle progression in nontransformed cells (Ryo et al. 2002) . Moreover, juglone or PIN1 siRNA blocks cell cycle progression and triggers cell death (Wiegand et al. 2009 ). In line with these reports, we found that treatment with juglone and PIN1 siRNA down-regulated protein and mRNA expression of PIN1 in a concentrationdependent manner (Fig. 1C; Appendix Fig.) . In addition, juglone inhibits PIN1 function by suppressing mRNA expression of PIN1 (Appendix Fig.) . These results suggest that juglone specifically affects PIN1 transcription, at least in PDLCs.
Our results revealed that juglone, a chemical inhibitor of PIN1, and PIN1 siRNA blocked the LPS-and nicotineinduced increases in iNOS and COX-2 expression, as well as NO and PGE 2 production. By contrast, PIN1 activation by Ad-PIN1 accentuated the LPS-and nicotine-induced inflammatory responses. These data suggest that PIN1 inhibition exerts anti-inflammatory effects in PDL cells in vitro. Our results are consistent with data showing that juglone reduced RA progress in a collagen-induced RA mouse model and suppressed COX-2 expression in human primary RA chondrocytes (Jeong HG et al. 2009 ).
Our results indicate that nicotine-and LPS-induced NF-κB activation was blocked by juglone and PIN1 siRNA and increased by PIN1 overexpression. Since the expression of these proinflammatory mediators is modulated by NF-κB, our findings suggest that the inhibition of proinflammatory mediator production by juglone and PIN1 siRNA was due to blockade of the NF-κB signaling pathway. These results are in agreement with a previous report that PIN1 knockdown decreased TNF-α-induced NF-κB activation in U251-MG cells, resulting in inhibition of IL-8 . Effect of PIN1 inhibition and overexpression on the osteoclastogenic effects of conditioned medium (CM) from nicotine-and LPS-treated PDLCs, as assessed using an in vitro osteoclast differentiation system (B-D). PDLCs were pretreated with adenovirus encoding PIN1 for 5 h, juglone for 1 h, and PIN1 small-interfering RNA for 12 h and then incubated with 5 mM nicotine and 1 µg/mL LPS for 24 h (A). PDLCs were cultured in the presence of 5 mM nicotine and 1 µg/mL LPS for 1 d, and CM was prepared as described in the Materials and Methods section. At the end of culture, cells were stained for tartrate-resistant acid phosphatase activity (B). The numbers of osteoclasts per well were counted (C). mRNA expression of osteoclast-specific marker genes was assessed by reverse transcription-polymerase chain reaction (D). Similar data were obtained from 3 independent experiments. #P < 0.05 versus CM collected from nicotine-and LPS-treated PDLCs.
expression (Atkinson et al. 2009 ). Similarly, NF-κB activation in PIN1-overexpressing chondrocytes is associated with overproduction of proinflammatory mediators in RA progression (Jeong HG et al. 2009 ). It was recently reported that Pin1 -/mice exhibit a defect in bone morphogenetic protein signaling in osteoblasts but normal osteoclast function (Shen et al. 2013 ). However, Islam et al. (2014) demonstrated wide variation in the sizes of osteoclasts in Pin1 -/mice, with very high numbers of large osteoclasts. Since Pin1 -/mice show significant bone loss with aging ), we examined whether PIN1 is involved in osteoclast differentiation as well as up-regulation of osteoclastogenic cytokine expression in BMMs (the culmination of this process is periodontal bone destruction). Osteoclast formation and expression of osteoclastogenic genes, such as cathepsin K, c-fos, and NFATc1, was inhibited by CM from juglone-and PIN1 siRNAtreated cells but increased by Ad-Pin1 CM. To our knowledge, this is the first demonstration that PIN1 mediates the inhibitory effect of nicotine and LPS on osteoclast differentiation.
It was recently demonstrated that periodontitis with inflammation or destruction of periodontal tissue and resorption of alveolar bone results in increased production of several osteoclastogenic cytokines, such as IL-1, IL-6, and TNF-β (Kobayashi et al. 2000; Kim et al. 2010 ). In the present study, inhibition of PIN1 by juglone or PIN1 siRNA blocked the nicotineand LPS-stimulated expression of TNF-α, IL-1β, IL-6, IL-11, IL-17, and IL-23, whereas PIN1 overexpression accentuated it. Our results suggest that induction of the expression of osteoclastogenic cytokines such as TNF-α, IL-1β, IL-6, IL-11, IL-17, and IL-23 by PIN1 modulation leads to osteoclast differentiation.
In summary, this study is the first to demonstrate that PIN1 inhibition blocks nicotine-and LPS-induced inflammatory responses and osteoclast differentiation, possibly through ) (C) in periodontal ligament cells (PDLCs). Cells were pretreated with PDTC (1 mM) for 1 h or NF-κB siRNA (30 nM) for 12 h (B-E). PDLCs were treated with Ad-PIN1 for 5 h, juglone for 1 h, and PIN1 siRNA for 12 h and then incubated with 5 mM nicotine and 1 µg/mL LPS for 24 h (A-E). mRNA and protein expression was determined by reverse transcriptionpolymerase chain reaction and Western blot analysis, respectively (A, D, E). Production of NO and PGE 2 was measured using the Griess assay and enzyme-linked immunosorbent assay, respectively (B, C). Data were obtained from 3 independent experiments. osteoclastogenic cytokines. PIN1 inhibition is a potential therapeutic strategy in osteolytic bone diseases such as periodontal disease.
